About Us
The dispatch vision
Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured.
To achieve this, we’re engineering a universal treatment across solid tumors, leveraging our first-in-class Flare platform. Our novel approach combines the strengths of immunotherapy with a tumor-specific viral vector — both engineered to clear tumor cells with precision and power — to expand the curative potential of immunotherapies for cancer patients.
Our vision is to empower people to continue forward with their lives — cancer-free.
Team
Since its founding, Dispatch has focused on building a world-class leadership team. In addition to a distinguished group of innovators and an experienced board of directors, Dispatch’s executive leadership possesses more than a century of combined drug development experience, supporting numerous IND filings and the launch of multiple new medicines for patients.
Aarshi Singh, Ph.D.
Technical Operations
Kole Roybal, Ph.D.
SAB Chairman; University of California, San Francisco
Sabah Oney, Ph.D.
Chief Executive Officer
Jeff Marrazzo, MBA, MPA
Founding Chairman; Co-founder and Former CEO, Spark Therapeutics
Andy Minn, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center (MSK)
Adam Haines, Ph.D.
Technical Operations
Andy Minn, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center (MSK)
Barbra Sasu, Ph.D.
Chief Scientific Officer
Carl June, M.D.
Perelman School of Medicine, University of Pennsylvania
Alex Goble
Technical Operations
Antoni Ribas, M.D., Ph.D.
University of California, Los Angeles
Jake Bauer
Venture Partner, ARCH Venture Partners
Chris Wiwi, Ph.D.
Senior Vice President, Technical Operations
Chris Garcia, Ph.D.
Stanford University
Alison Blaus
Regulatory
Anusha Kalbasi, M.D.
Stanford University
Kole Roybal, Ph.D.
SAB Chairman; University of California, San Francisco
John Connolly, Ph.D.
Chief Scientific Officer, Parker Institute for Cancer Immunotherapy
Alyse Frisbee, Ph.D.
Technical Operations
Lex Johnson, Ph.D.
Co-Founder and Chief Platform Officer
Brad Rosenberg, M.D., Ph.D.
Icahn School of Medicine at Mount Sinai
Robert Nelsen
Co-founder and Managing Director, ARCH Venture Partners
Jennifer Flaisher
Chief People & Culture Officer
Amanda Munshower
Technical Operations
Ray Liu, Ph.D.
Co-founder and Head of Synthetic Biology
Carl June, M.D.
University of Pennsylvania
Sabah Oney, Ph.D.
CEO, Dispatch
Lex Johnson, Ph.D.
Co-Founder and Chief Platform Officer
Andrew Devaney
Virology Research
Chris Garcia, Ph.D.
Stanford University
Naveen Bazaj
Senior Vice President, Corporate Development
Sean Parker
Founder and Chairman, Parker Institute for Cancer Immunotherapy
Andrew Miller
Program & Portfolio Management
Christine Brown, Ph.D.
City of Hope
Steve Gillis, Ph.D.
Managing Director, ARCH Venture Partners
David Kirn, M.D.
University of California, Berkeley; 4D Molecular Therapeutics
Anna Wolfe
Virology Research
John Connolly, Ph.D.
PICI
Barbra Sasu, Ph.D.
Research
Kristen Hege, M.D.
University of California, San Francisco
Benjamin Schott, Ph.D.
Research
Lisa Coussens, M.D., Ph.D., FAACR, FAIO
Oregon Health & Science University
Brendan O’Hara
Research
Matt Porteus, M.D., Ph.D.
Stanford University
Catherine Sierra
Research
Chris Wiwi, Ph.D.
Technical Operations
Dan Piraner, Ph.D.
Research
David Heo
Technical Operations
Elizabeth Campbell, Ph.D.
Research
Guillermo Ortiz Ahedo
Technical Operations
Harris Xanthos, Pharm.D.
Program & Portfolio Management
Henri Estanbouli
Technical Operations
Jamie Guilliams
Technical Operations
Jason DeHart, Ph.D.
Virology Research
Jaymes Fuller
Technical Operations
Jennifer Flaisher
People & Culture
Jerick Sanchez
Research
Jevin Frazer-Wrobeh
Technical Operations
Jimmy Lee
Research
John Johnson, Ph.D.
Research
Jonathan Hale
Research
Joseph Kocis
Program & Portfolio Management
Kalvin Chan
Research
Lex Johnson, Ph.D.
Research, Co-Founder
Lisa Cucolo, Ph.D.
Research
Mark Rukhman
Technical Operations
Michael Ball, Ph.D.
Research
Michael Ruggiero
Technical Operations
Mike Hanson, Ph.D.
Technical Operations
Naveen Bazaj
Corporate Development
Nick Grams, Ph.D.
Virology Research
Nishi Gheewala
Research
Nishi Kothari, M.D.
Clinical
Patricia Brafford
Research
Ray Liu, Ph.D.
Research, Co-Founder
Rebecca Broeckel, Ph.D.
Virology Research
Roman Subbotin, Ph.D.
Technical Operations
Ryan Shorr
Technical Operations
Sabah Oney, Ph.D.
Chief Executive Officer
Sahil Joshi
Research
Siler Panowski, Ph.D.
Research
Stanley Newman
Facilities & Real Estate
Sue Burns
Administration
Surabhi Srinivasan
Research
Tara McGrath
Research
Tatiana Garcia-Bates, Ph.D.
Research
Tracy Yenshaw
Finance
Tyler Fallon
Virology Research
Weichao Zhuo
Research
Whitney Gladney, Ph.D.
Research
Yemaiza Ojeda-Lassalle
Technical Operations
Join us as we work to revolutionize cancer treatment
Each and every one of us is integral to our success.